SUMMARY Cape Town has a Greek community of about 5000, of whom approximately 75% originate from the island of Lesbos. In a survey of inherited haematological conditions in this population, 250 unrelated volunteers were investigated.
The prevalence of heterozygous 3-thalassaemia was found to be 6 4%, with a gene frequency of 0 033. G6PD deficiency was detected in 10 males and it can be estimated that the prevalence in the male members of this population is 6 *7 %, with a gene frequency of 0 *067. Hereditary spherocytosis was found in three respondents and this represents a prevalence of 1 *2 %, with a gene frequency of 0 -006. One subject was heterozygous for the sickle cell trait (HbS) and another volunteer had haemoglobin Lepore, which had already been diagnosed in Greece.
Our findings with respect to 3-thalassaemia and G6PD deficiency are similar to those reported from regions in Greece where malaria is not highly endemic.
Every well-defined population has a particular pattern of genetic disorders. Inherited anaemias, notably glucose-6-phosphate dehydrogenase deficiency (G6PD), P-thalassaemia, and spherocytosis occur with significant frequency in people of Greek stock in South Africa.
Programmes for management, control, and prevention of inherited conditions are dependent upon basic information concerning the prevalence and clinical consequences of the disorders in question. For these reasons we have undertaken a survey of familial haematological disorders in the Greek community of Cape Town. Our findings are presented and discussed in this paper.
Demography
The first Greeks to visit South Africa were seamen, who arrived in the middle of the last century. Following the discovery of diamonds and gold, there was a general influx of immigrants from many countries, and by 1900 Cape Town had a Greek population of approximately 1000. At this time a Greek orthodox priest from Crete was sent to Cape Town to found a Greek community, and in the following decade additional communities were Received for publication 9 August 1978 established in Johannesburg and Pretoria (Nickolaides, 1923 A letter was sent to all Greeks in Cape Town explaining the aims and purpose of the study and prospective subjects were invited to volunteer for blood sampling. Members of the Greek community were addressed at a cinema club where they met regularly. At subsequent film evenings a slide concerning the study was shown as a reminder. A further source of respondents was the in-patients of Greek stock at Groote Schuur Hospital who had been admitted for non-haematological disorders. Ascertainment continued until 250 unrelated respondents, representing 5 % of the community, had been studied. These comprised 150 males and 100 females.
A brief clinical history was obtained from each volunteer, with emphasis on anaemia, jaundice, gallstones, malaria, and drug reactions. Respondents were examined if an inherited haematological disorder was suspected, and in these circumstances special attention was paid to the presence or absence of hepatosplenomegaly.
A 20 ml venous blood specimen was obtained from each of the respondents for haematological and biochemical investigations. The following standard laboratory procedures were undertaken.
(1) Peripheral blood smears: red cell morphology. (Black et al., 1966) . (6) Quantification of haemoglobin F (Singer et al., 1951) . (7) Brilliant cresyl blue dye test (Motulsky and Campbell-Kraut, 1961 deficiency (Brewer et al., 1962) .
(9) Solubility test for haemoglobin S (Itano, 1953) .
(10) Autohaemolysis studies if spherocytosis was suspected (Dacie and Lewis, 1975) .
The requirements for recognising r-thalassaemia trait were: abnormality in 2 of 3 haematological criteria, (a) red cell morphology, (b) increased osmotic resistance, (c) decreased mean cell haemoglobin; and abnormality in one of the biochemical criteria, (a) increase in haemoglobin A2 above 3 %, (b) increase in haemoglobin F above 2%. For the diagnosis of o-thalassaemia trait, a search for red cell inclusion bodies of haemoglobin H type was added to the haematological criteria, of which 3 of 4 had to be abnormal and, as biochemical criterion, the presence of a fast-moving haemoglobin was substituted for abnormality of haemoglobin A2 or haemoglobin F. The method of Black et al. (1966) for estimating haemoglobin A2 was used for economy, but a random 10 % of all specimens, as well as abnormal specimens, were retested by elution from cellulose-acetate. Discrepancies did not occur.
For the diagnosis of haemoglobin S, both paper and agar electrophoresis were applied, and decreased solubility was shown by Itano's test (Itano, 1953) .
For G6PD activity, the test of Motulsky and Campbell-Kraut (1961) was used; in the case of females with minimally prolonged test times, methaemoglobin reduction (Brewer et al., 1962) was used for confirmation.
Hereditary spherocytosis was recognised by a combination of increased osmotic fragility, particularly after incubation at 370 for 24 hours; increased autohaemolysis after similar incubation, which was corrected or much decreased by the addition of glucose; and the presence of a proportion of microspherocytes in the peripheral blood. From the random nature of the survey it proved difficult to arrange family investigations which may have given confirmation in the doubtful instances.
Results
The following haematological disorders were identified among the 250 respondents from the Greek population of Cape Town.
(a) THALASSAEMIA Sixteen people heterozygous for r-thalassaemia were diagnosed on haematological and biochemical grounds. The overall prevalence of heterozygous r-thalassaemia in the Greek community was 6 4%, with a gene frequency of 0-032. Not included in the 250 random subjects, but previously encountered, were two locally born subjects of Greek origin with homozygous r-thalassaemia (thalassaemia major). When a distinction is made (Kattamis et al., 1978) between heterozygous r-thalassaemia (with increased haemoglobin A2 and haemoglobin F less Inherited anaemias in the Greek community of Cape Town than 5%) and heterozygous 83-thalassaemia (with normal haemoglobin A2 and haemoglobin F increased above 5 .), the latter condition was not recognised in the random sample. However, 6p-thalassaemia trait was previously recognised locally in two instances. Found during the survey was a subject with normal haemoglobin A2 and slightly raised haemoglobin F with haematological stigmata in keeping with heterozygous 3-thalassaemia. This may represent the type of thalassaemia trait with no, or only slight, biochemical abnormality, but which may nevertheless interact with the classical 3-thalassaemia trait to produce the full picture of homozygous 3-thalassaemia (Malamos et al., 1962; Kattamis et al., 1978) . The ratio of r-thalassaemia trait to 83-thalassaemia trait in Greece, calculated from data of Malamos et al. (1962) and Kattamis et al. (1978) , is approximately of the order of 10:1.
One might, therefore, have expected to find a 6p-heterozygote in the present survey.
a-thalassaemia was not recognised in this study, but the gene is known to be present among local Greeks from previous cord blood surveys (M. C. Botha, 1978, unpublished data) .
(b) G6PD DEFICIENCY Thirteen subjects were found to have G6PD deficiency. Of these, 10 were male and 3 female. The prevalence of G6PD deficiency in the males was 6-7 %, with a gene frequency of 0 067. These figures have been calculated only for the males, as the diagnosis can be missed in a proportion of heterozygous females.
(C) HEREDITARY SPHEROCYTOSIS Of the 250 subjects, 3 were found to have hereditary spherocytosis and the prevalence of this condition was 1 -2 %, with a gene frequency of 0 006. Four other people in the survey had laboratory findings which were highly suggestive of hereditary spherocytosis, but the diagnosis could not be established with absolute certainty. On this basis, the prevalence could be as high as 2 5 %, with a corresponding gene frequency of 0 0125. A recent immigrant volunteered for the survey with the knowledge that he had haemoglobin Lepore, initially diagnosed in Greece.
Discussion
The frequency of the gene for r-thalassaemia was within the range found in Greece. In a random population study an incidence of 7 -44 % was reported (Malamos et al., 1962) , and in a regional study, based on malarial endemicity, the frequency ranged from 6-1 to 19 7 % with a mean of 14 25 % (Stamatoyannopoulos and Fessas, 1964) . The frequency of G6PD deficiency among Greeks in Cape Town was similar to that found in areas of Greece where malaria was not highly endemic, the prevalence being reported as 33 Y% in malaria-free areas, 4*5 % in moderately endemic regions, and 198 % in several endemic regions. Information specific to Lesbos was not found, but it is noteworthy that the prevalence of G6PD deficiency on islands such as Corfu and Serifos is low or the condition is absent (Stamatoyannopoulos and Fessas, 1964) .
The considerable discrepancies in the frequency of these genes in various parts of Greece is probably a reflection of biological advantage in terms of protection against malaria, which was, until recently, endemic in the Greek islands (Motulsky, 1960 From the practical point of view, the form of G6PD deficiency in the Greek population is usually a mild disease which causes little morbidity, and haemolysis on exposure to certain drugs is the major complication. However, two subjects in our series had previously experienced acute haemolytic crises which necessitated urgent hospital admission, and on this basis the condition certainly has clinical significance.
Laboratory diagnosis is comparatively easy and population screening would be worthwhile, as identification of affected people could form the basis for prevention by avoidance of known precipitating factors. Subjects identified during our survey were informed of these hazards and given a list o medicines which were contraindicated. This information was also passed on to their general practitioners.
Homozygous 3-thalassaemia is a serious disease which causes considerable disability and compromises the life span. The heterozygous carrier of the abnormal gene frequently is virtually asymptomatic, but recognition of 'at risk' couples by population screening merits consideration now that antenatal diagnosis of the condition is feasible (Hobbins and Mahoney, 1974; Fairweather et al., 1978) .
Spherocytosis does not always cause clinical problems and may only be detected in laboratory investigation of relatives of patients with overt symptoms. However, there is a risk of episodes of anaemia and an increased incidence of cholelithiasis as a result of chronic haemolysis. The prevalence of spherocytosis in the Greek community of Cape Town is much higher than the figure of 1/10000 which is quoted for Europe. There are no comparable data for the Mediterranean region, but it is reasonable to speculate that the founder effect has been operative.
It is generally accepted that unexplained anaemia in a subject of Greek stock in South Africa should arouse suspicion of a familial disorder of this type. Confirmation of the relatively high prevalence of these hereditary conditions by this survey provides a scientific basis for this clinical attitude.
